Evidence map›Paper›PMID 41533571›Full record

ArticleNucleic acids research2026

RaptScore: a large language model-based algorithm for versatile aptamer evaluation.

Akira Kimura-Yamazaki, Tatsuo Adachi, Shigetaka Nakamura, Yoshikazu Nakamura, Michiaki Hamada

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Akira Kimura-YamazakiGraduate School of Advanced Science and Engineering, Waseda University, Shinjuku-ku Okubo 3-4-1, 169-0072 Tokyo, Japan.ORCID 0009-0005-3336-3953
Tatsuo AdachiRIBOMIC, Minato-ku Shirokanedai 3-16-13, 108-0071 Tokyo, Japan.
Shigetaka NakamuraRIBOMIC, Minato-ku Shirokanedai 3-16-13, 108-0071 Tokyo, Japan.
Yoshikazu NakamuraRIBOMIC, Minato-ku Shirokanedai 3-16-13, 108-0071 Tokyo, Japan.
Michiaki HamadaGraduate School of Advanced Science and Engineering, Waseda University, Shinjuku-ku Okubo 3-4-1, 169-0072 Tokyo, Japan.ORCID 0000-0001-9466-1034

Funding

CREST JPMJCR1881CREST JPMJCR21F1JSTKAKENHI 22H04925KAKENHI 23H00509KAKENHI 24K21326KAKENHI 25H00427KAKENHI 25H01310KAKENHI JPNP23003New Energy and Industrial Technology Development OrganizationWaseda University
6 · The paper itself

Abstract

RNA aptamers are a high-potency tool in the life sciences, offering promising applications in drug discovery and beyond. They are typically obtained through systematic evolution of ligands by exponential enrichment (SELEX), which imposes constraints on sequence length and diversity. Several metrics, such as frequency and enrichment, have been developed to identify high-activity aptamers from SELEX. However, existing evaluation metrics are limited to sequences that appear within SELEX and cannot assess sequences of varying lengths, limiting their utility in optimizing aptamer design. To overcome these limitations, we developed RaptScore, a novel binding activity evaluation metric leveraging large language models. RaptScore enables the assessment of arbitrary sequences, including those absent from SELEX, and accommodates variations in sequence length. RaptScore exhibited a strong correlation with binding activity, allowing the identification of shorter aptamers with enhanced binding properties. By integrating RaptScore with in silico maturation, we achieved a 10-nucleotide truncation while maintaining binding efficiency. Furthermore, we demonstrated improved aptamer discovery efficiency by combining RaptScore with RaptGen, a variational autoencoder-based aptamer discovery tool. By enabling efficient sequence evaluation and optimization, RaptScore provides a powerful tool for aptamer research, facilitating the discovery of high-activity candidates while reducing experimental effort.

Indexed as

AlgorithmsAptamers, NucleotideSELEX Aptamer TechniqueLarge Language ModelsAptamers, Nucleotide

Identifiers

PMID41533571
PMCPMC12802916

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.